Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating escitalopram for Irritable Bowel Syndrome in patients with panic disorder has completed; no efficacy results are provided in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Irritable Bowel Syndrome, Panic Disorder | Phase 4 | Status: COMPLETED